The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases
Open accessAbstract
Solid tumors of various etiologies can be treated efficiently by electrochemotherapy (ECT), a combined use of electroporation (EP) and chemotherapeutic drugs, such as bleomycin and cisplatin. EP alone and ECT in particular, induce a profound reduction in tumor blood flow, which contributes to the antitumor effect. After EP and ECT, the time course of blood flow changes and follows the same two-phase pattern. The first rapid and short-lived vasoconstriction phase is followed by the second much longer-lived phase resulting from disrupted cytoskeletal structures and a compromised barrier function of the microvascular endothelium. In the case of ECT, however, tumor vascular endothelial cells are also affected by the chemotherapeutic drug, which leads to irrecoverable damage to tumor vessels and to a further decrease in tumor blood flow within hours after application of ECT. Tumor cells surviving the direct effects of ECT are consequently exposed to lack of oxygen and nutrients and are pushed into the secondary cascade of induced cell death. Clinically, the antitumor effectiveness of ECT has been proven extensively in the treatment of melanoma metastases, with 70-80% complete responses. The antivascular effects of ECT were also exploited for palliative treatment of bleeding melanoma metastases, with immediate cessation of bleeding and very good antitumor effectiveness. The antivascular effect of ECT is of utmost importance for translation of ECT into the treatment of deep-seated tumors, especially in well vascularized organs, such as the liver, where it prevents bleeding of the treated area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The endothelial cytoskeleton as a target of electroporation-based therapies
Kanthou, C., Kranjc, S., Sersa, G., Tozer, G., Zupanic, A., & Cemazar, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0410 · Cited by 129
Cited by
Electroporation-Based Technologies for Medicine: Principles, Applications, and Challenges
Yarmush, M. L., Golberg, A., Serša, G., Kotnik, T., & Miklavčič, D. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104622 · Cited by 889
Geboers, B., Scheffer, H. J., Graybill, P. M., Ruarus, A. H., Nieuwenhuizen, S., Puijk, R. S., van den Tol, P. M., Davalos, R. V., Rubinsky, B., de Gruijl, T. D., et al. (2020) · Radiology · doi:10.1148/radiol.2020192190 · Cited by 385
Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis
Mali, B., Jarm, T., Snoj, M., Sersa, G., & Miklavcic, D. (2013) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2012.08.016 · Cited by 353
Self-citationA Comprehensive Review of Calcium Electroporation—A Novel Cancer Treatment Modality
Frandsen, S. K., Vissing, M., & Gehl, J. (2020) · Cancers · doi:10.3390/cancers12020290 · Cited by 132
Sano, M. B., Neal, R. E., Garcia, P. A., Gerber, D., Robertson, J., & Davalos, R. V. (2010) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-9-83 · Cited by 117
Metadata
- Authors
- Jarm, T., Cemazar, M., Miklavcic, D., & Sersa, G.
- Venue
- Expert Review of Anticancer Therapy
- Publisher
- Informa UK Limited
- Published
- 2010-05
- Volume
- 10
- Issue
- 5
- Pages
- 729-746
- ISSN
- 1473-7140 (ISSN-L)
- 1744-8328
- OpenAlex
- W2098851488
- Cited by
- 224
- References
- 1
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. https://app.cochat.ai/papers/10.1586/era.10.43
- The paper
- Jarm, T., Cemazar, M., Miklavcic, D., & Sersa, G. (2010). Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Review of Anticancer Therapy. https://doi.org/10.1586/era.10.43
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.